In Alzheimer’s disease model mice, the intravenous infusion of hUCBCs increases the levels of anti-inflammatory cytokines in plasma and reduces the level of circulating sCD40L, an important mediator of inflammation35. Here, CD40LG is linked to early-onset autosomal dominant Alzheimer disease.